BANK OF AMERICA CORP /DE/ - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 92 filers reported holding CTI BIOPHARMA CORP in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$14,744,851
+164.8%
3,510,679
+279.0%
0.00%
+100.0%
Q4 2022$5,567,442
+33.8%
926,363
+29.5%
0.00%
Q3 2022$4,162,000
+171.0%
715,063
+177.9%
0.00%
Q2 2022$1,536,000
+5385.7%
257,283
+4260.7%
0.00%
Q1 2022$28,000
+833.3%
5,900
+354.5%
0.00%
Q4 2021$3,000
-95.9%
1,298
-94.8%
0.00%
Q3 2021$74,00025,111
+75993.9%
0.00%
Q2 2021$033
-31.2%
0.00%
Q2 2020$0
-100.0%
48
-99.1%
0.00%
Q3 2019$4,000
-97.8%
5,341
-97.5%
0.00%
Q2 2019$186,000
+2557.1%
216,316
+2616.5%
0.00%
Q1 2019$7,000
-53.3%
7,963
-62.0%
0.00%
Q4 2018$15,000
-40.0%
20,967
+82.9%
0.00%
Q3 2018$25,000
-21.9%
11,462
+77.1%
0.00%
Q2 2018$32,000
-46.7%
6,472
-57.8%
0.00%
Q1 2018$60,00015,329
+170222.2%
0.00%
Q4 2017$0
-100.0%
9
-96.4%
0.00%
Q3 2017$1,0000.0%247
+8.8%
0.00%
Q2 2017$1,000227
+1094.7%
0.00%
Q1 2017$0190.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 6,535,674$27,449,8319.21%
Bleichroeder LP 3,893,730$16,353,6663.49%
AIGH Capital Management LLC 2,100,000$8,820,0003.25%
Ally Bridge Group (NY) LLC 550,000$2,310,0003.03%
Ghost Tree Capital, LLC 2,000,000$8,400,0002.48%
Bain Capital Life Sciences Investors, LLC 4,702,996$19,7532.47%
Altium Capital Management LP 850,000$3,570,0001.98%
Parkman Healthcare Partners LLC 1,753,630$7,365,2461.60%
BVF INC/IL 8,813,021$37,014,6881.35%
Sio Capital Management, LLC 526,239$2,210,2041.09%
View complete list of CTI BIOPHARMA CORP shareholders